
Carlsmed® uses patient data and digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices.
CARLSMED, INC. has raised $103.0M in total funding. The most recent round was Series C.
CARLSMED, INC. is headquartered in Carlsbad, CA.
Carlsmed® uses patient data and digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices.
Standard, non-personalized approaches to spine surgery limit patient outcomes and drive up the cost of care.
Carlsmed's aprevo platform provides data-driven 3D surgical planning, visualization, and precision alignment to create a personalized spinal implant and procedure for each individual patient.
The site states aprevo is FDA-cleared for lumbar and cervical spinal fusion, backed by a dedicated clinical evidence program, and has newly secured favorable CMS reimbursement (new Medicare Severity-Diagnosis Related Groups) for aprevo lumbar procedures.
Carlsmed, maker of the aprevo personalized spine implant system, has raised over $100M in venture funding, including a $52.5M Series C co-led by B Capital and U.S. Venture Partners.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.